Abstract
Dantrolene sodium, a hydantoin derivative, relaxes skeletal muscle by a peripheral rather than a central action by inhibiting release of calcium from the sarcoplasmic reticulum (SR). Both resting and twitch tensions are decreased in the presence of dantrolene. The action of dantrolene on the SR may be indirect rather than direct. Thus in both isolated SR preparations and in skinned fibre preparations dantrolene does not greatly alter caffeine, calcium or chloride induced calcium release from the SR.
Dantrolene prolongs the action potential duration and effective refractory period of normal polarized Purkinje muscle. Dantrolene also blocks calcium release from vascular smooth muscle. Dantrolene depresses canine urethral and bladder pressures and reduces the amplitude of calcium induced contractions of rabbit jejunum.
Dantrolene is formulated in 70 cc bottles which contain 20 mg of dantrolene, 3.0 grams of mannitol and enough sodium hydroxide to raise the pH to 9.5 when the material is reconstituted with 60 ml of water. This rather unusual formulation is necessary because of the relative water insolubility of dantrolene. Care must be taken not to allow extravasation of dantrolene into the tissues because the high pH of the solution would be injurious to the tissues. The vein site should be changed every few hours to avoid serious thrombophlebitis.
Since the introduction of dantrolene a marked improvement in survival from malignant hyperthermic (MH) reactions has occurred. While some of this improvement has probably been due to other factors (better monitoring and better education of anaesthetists about the diagnosis and management of MH reactions) a considerable portion of the improvement must be attributed to the use of dantrolene.
The dose of dantrolene required to successfully resuscitate patients from MH reactions has varied from less than 1.0 to 17 mg/kg. All patients who have received, early in the reaction, at least 6.0 mg/kg of the official formulation have survived. The drug is administered as a bolus at a maximal rate of I mg/kg/minute up to a maximum of 10 mg/kg under EKG control. This bolus may be repeated every 15 minutes. Once temperature, heart rate and muscle stiffness have begun to decline, an IV drip containing 1–2 mg/kg of dantrolene may be administered over a three to four hour period.
In patients dying in spite of the use of dantrolene, one or more of the following has usually been present: use of a non-official formulation; delay in commencing dantrolene; use of an insufficient amount of dantrolene; concomitant use of contraindicated drugs; true diagnosis not malignant hyperthermia. In pigs dantrolene has been effectively used prophylactical ly, to prevent halothane induced MH reactions, in doses ranging from 5 to 24 mg/kg in up to four divided doses. Dantrolene has also been used in MH humans prior to elective anaesthesia. Because deliberate halothane challenge is impossible in human patients its efficacy in this species is difficult to determine.
In some, but not all, MHS patients, dantrolene has reduced the severity of the skeletal muscle aches, pains and cramps from which these individuals not infrequently suffer. Dantrolene is also useful in certain other situations involving non MH patients. For instance, dantrolene is valuable in the management of heat stroke, neuroleptic malignant syndrome, cerebral palsy, Parkinsons disease, chorea, athetosis, spinal cord injury, multiple sclerosis, myotonia and tetanus. Dantrolene also attenuates succinylcholine induced muscle fasciculations, postoperative muscle pains and rises in serum potassium.
Early undesirable but transient effects of dantrolene include dizziness, diplopia, dysarthria, sensations of muscle weakness and swelling of the eyeballs and tongue. These symptoms disappear a few hours after discontinuation of the drug. Liver damage, chronic pleural effusion, acute pericarditis and lymphocytis have rarely been reported but their true relationship to dantrolene ingestion has not been well documented. Long term high dose dantrolene therapy rather consistently causes a fine cuneiform rash over the face and back.
Dantrolene is metabolized through reductive and oxidative pathways. The nitro group of dantrolene is reduced to amino-dantrolene. The amine group is acetylated. Oxidation of dantrolene produces 5-OH dantrolene.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Norwich-Eaton Pharmaceuticals (Division of Norwich-Eaton, Ltd.). 1979. Dantrium Intravenous (Dantrolene Sodium Intravenous). Product Monograph.
Snyder, Jr., H.R., Davis, C.S., Bickerton, R.K. and Halliday, R.P. J. Med. Chem. 1967;10:807.
Lee, C, Durant, N.N., Au, E. and Katz, R.L. Anesthesiology 1981;54:61.
Ellis, K.O. White, Jr., R.L., Wright, G.C. and Wessels, F.L. J, Pharm. Sci. 1980;69;327.
Ward, A., Chaffman, M.O. and Sorkin, E.M. Drugs 1986;32:130.
Hackett, L.P. and Dusci, L.J. J. Chromatography 1979;179:222.
Hollifield, R.D. and Conklin, J.D. Arch. int. Pharmacodyn. 1968;174:333.
Hollifield, R.D. and Conklin, J.D. J. Pharm. Sci. 1973;62:271.
Ellis, K.O. and Wessels, F.L. Nauyn-Schmiedeberg1 s Arch. Pharmacol. 1978;301:237.
Cox, P.L., Heotis, J.P., Polin, D. and Rose, G.M. J. Pharmaceutical Sci. 1969;58:987.
Ellis, K.O., Castellion, A.W., Honkomp, L.J., Wessels, F.L., Carpenter, J.F. and Halliday, R.P. J. Pharm. Sci. 1973;62:948.
Krarup, C. J. Physiol. 1981; 311:389.
Britt, B.A., Scott, E., Frodis, W., Clements, M-J. and Endrenyi, L. Can. Anaesth. Soc. J. 1984;31:130.
Anderson, I.L., Lipicky, R.J. and Jones, E.W. In: Aldrete, J.A. and Britt, B.A. (eds.). Second International Symposium on Malignant Hyperthermia. 1978. New York: Grune & Stratton, p. 509.
Ellis, K.O. and Wessels, F.L. In: Wasserman, R.H. et al. (eds.). Calcium-binding proteins and calcium function: Proceedings of the 2nd International Symposium on Calcium-Binding Proteins and Calcium Function in Health and Disease, Cornell University, Ithaca, N.YU., June 5–90, 1977, pp. 273–274, North-Holland, Amsterdam, 1977.
Nelson, T.E. Anesthesiology 1983;59:A225.
Yamamoto, Y., Suzuki, A. and Hotta, K. Jap. J. Physiol. 1977;27:95.
Nott, M.W. and Bowman, W.C. Clin. Exp. Pharmacol. Physiol. 1974;1:113.
Ellis, K.O. and Bryant, S.H. Naunyn-Schmiedeberg’s Arch. Pharmacol. 1972; 274:107.
Desmedt, J.E. and Hainaut, K. J. Physiol. 1977;265:565.
Ellis, K.O. and Carpenter, J.F. Naunyn-Schmiedeberg’s Arch. Pharmacol. 1972;275:83.
Putney, Jr., J.W. and Bianchi, C.P. FEBS 1973;32:772.
Moulds, R. Brit. J. Pharmacol. 1977;59:129.
Halsall, P.J. and Ellis, F.R. Br. J. Anaesth. 1979;51:753.
Fairhurst, A.S., Hamamoto, V. and Macri, J. Anesthesiology 1980;53:199.
Okumura, F., Crocker, B.D. and Denborough, M.A. Br. J. Anaesth. 1980;52:377.
Brocklehurst, L. Nature 1975;254:364.
Oba, T. Can. J. Physiol. Pharmacol. 1981;59:358.
Morgan, K.G. and Bryant, S.H. J. Pharmacol. Exp. Therap. 1977;201:138.
Korczyn, A.D., Shavit, S. and Schlosberg, I. Eur. J. Pharmacol. 1980;61:187.
Ellis, K.O. and Carpenter, J.F. Fed. Proc. 1971;30:670.
Leslie, G.C. and Part, N.J. Br. J. Pharmac. 1984;81:351.
Flewellen, E.H., Nelson, T.E. and Bee, D.E. Anesthesiology 1980;52:126.
Desmedt, J.E. and Hainaut, K. Biochem. Pharmacol. 1979;28:957.
Leslie, G.C. and Part, N.J. Br. J. Pharmac. 1981;72:665.
Tamai, Y. Electroencephalotraphy and Clinical Neurophysiology (Suppl.) 1982;36:221.
Kotsias, B.A. and Muchnik, S. Arch. Neurol. 1978;35:734.
Miglietta, O. Am. J. Phys. Med. 1977;56:293.
Miyamoto, H. and Racker, E. J. Membrane Biol. 1982;66:193.
Flewellen, E.H., Nelson, T.E. and Bee, D.E. Canad. Anaesth. Soc. J. 1980;27:16.
Nelson, T.E. and Flewellen, E.H. Canad. Anaesth. Soc. J. 1979;26:484.
Anderson, I.L. and Jones, E.W. Anesthesiology 1976;44:57.
Anderson, I.L., Rawstron, R.E. and Dunlop, D.J. N.Z. Med. J. 1980;91:417.
Nelson, T.E. In: Aldrete, J.A. and Britt, B.A. (eds.). Second International Symposium on Malignant Hyperthermia. 1978. New York: Grune & Stratton, p. 23.
Fletcher, J.E. and Rosenberg, H. Anesthesiology 1985;63:190.
Nelson, T.E. and Denborough, M.A. Clin. Exp. Pharmacol. Physiol. 1977:4:315.
Casson, H. and Downes, H. In: Aldrete, J.A. and Britt, B.A. (eds.). Second International Symposium on Malignant Hyperthermia. 1978. New York: Grune & Stratton, p. 3.
Sengupta, C, Meyer, U.A. and Carafoli, E. FEBS 1980;117:37.
Harrison, G. In: Huelsz et al. (eds.). Anaesthesiology. 1977. Amsterdam: Exerpta Medica, p. 452.
Harrison, G.G. Br. J. Anaesth. 1975;47:62.
Hall, G.M., Lucke, J.N. and Lister, D. Anaesthesia 1977;32:472.
Hall, G.M., Lucke, J.N. and Lister, D. Br. J. Anaesth. 1980;52:165.
Hall, G.M., Lucke, J.N., Orchard, C, Lovell, R. and Lister, D. Anaesthesia 1982;37:1167.
Gronert, G.A., Milde, J.H. and Theye, R.A. Anesthesiology 1976;44:488.
Kerr, D.D., Wingard, D.W. and Gatz, E.E. In: Aldrete, J.A. and Britt, B.A. (eds.). Second International Symposium on Malignant Hyperthermia. 1978. New York: Grune & Stratton, p. 499.
Hall, L.W., Trim, CM. and Woolfe, N. Br. Med. J. 1972;2:145.
Allen, P., Lopez, J.R., Jones, D. Alamo, L., Papp, L. et al. Anesthesiology 1985;63 (Suppl. 3A):268.
Verburg, M.P., Oerlemans, F.T.J.J., van Bennekom, C.A., Gielen, M.J.M., de Bruyn, C.H.M.M. and Crul, J.R. Acta Anaesthesiol. Scand. 1984;28:1.
Harrison, G.G. Br. J. Anaesth. 1977;49:315.
Flewellen, E.H. and Nelson, T.E. Anesthesiology 1980;52:303.
Nelson, T.E. and Flewellen, E.H. Anesthesiology 1979; 50:118.
Flewellen, E.H. and Nelson, T.E. FEBS 1978;37:331.
Lopez, J.R., Alamo, L., Jones, D., Allen, P., Lapp, L., et al. Anesthesiology 1985;63(Suppl. 3A):273.
Lopez, J.R., Alamo, L., Jones, D., Allen, P.D., Papp, L., et al. Biophys. J. 1985;47(Part 2):313A.
Rosenberg, H. (Letter). Can. Anaesth. Soc. J. 1980;27:304.
Lambert, W. (Letter). Can. Anaesth. Soc. J. 1980;27:304.
Britt, B.A. In: Milton, A.S. (ed.). Handbook of Experimental Pharmacology, Pyretics and Antipyretics. 1982. Heidelberg: Springer-Verlag, p. 547.
Gallant, E.M., Godt, R.D. and Gronert, G.A. Muscle and Nerve 1979;2:491.
Sullivan, J.S. and Denborough, M.A. Br. J. Anaesth. 1981;53:1217.
White, M.D. and Denborough, M.A. J. Gen. Pharmacol. 1984;15:129.
Araki, M., Takagi, A., Fujita, T. and Matsubara, T. Biomed. Res. 1985;6:73.
Nelson, T.E. FEBS Letters 1984; 167:123.
Ohnishi, S.T., Taylor, S. and Gronert, G.A. FEBS Letters 1983;261:103.
White, M.D., Collins, J.G. and Denborough, M.A. Biochem. J. 1983;212:399.
Stadhouders, A.M., Vïering, W.A.L., Verburg, M.P., Ruitenbeek, W. and Sengers, R.C.A. Acta Anaesth. Scand. 1984;28:14.
Cheah, K.S. Presented at the 4th International Malignant Hyperthermia Workshop, York, 1986.
Butterfield, J.L. and Ellis, K.O. Fed. Proc. 1973;32:772.
Ellis, K.O., Wessels, F.L. and Carpenter, J.F. J. Pharmaceutical Sci. 1976;65:1359.
Ellis, K.O., Butterfield, J.L., Wessels, F.L. and Carpenter, J.F. Arch. Int. Pharmacodyn. Ther. 1976;224:118.
Gollan, F. and McDermott, J. Proc. Soc. Exp. Biol. Med. 1979;160:42.
Bowman, W.C., Houston, J., Khan, H.H. and Rodger, I.W. Eur. J. Pharmacol. 1979;55:293.
Gronert, G.A. Anesthesiology 1980;53:395.
Ellis, R.H., Simpson, P., Tatham, P., Leighton, M. and Williams, J. Anaesthesia 1975;30;318.
Lullmann, H. and Schramm, U. Pharmacol. Res. Comm. 1982;14:967.
Wendt, I.R. Proceedings of the Australian Physiological and Pharmacological Society 1979; 10:132.
Bers, D.M., Philipson, K.D. and Langer, G.A. Am. J. Physiol. 1981;240:576.
Hiraoka, M., Kinoshita, H. and Kawano, S. Abstract. Proceedings of the IUPHAR 9th International Congress of Pharmacology, 92, 1984.
Hiraoka, M., Kinoshita, H. and Kawano, S. Jap. J. Physiol. 1985;35:123.
Honerjager, P. and Alischewski, N. Nauyn-Schmiedeberg’s Arch. Pharmacol. 1983;322:237.
Meszaros, J., Kecskemeti, V. and Szegi, J. Arch. Int. Pharmacyn. Therap. 1982;255:256.
Meyler, W.J., Wesseling, H. and Agoston, S. Eur. J Pharmacol. 1976;39:127.
Plizga, A. and Hoi I, J.E. Res. Comm. Chem. Pathol. Pharmacol. 1980;28:13.
Roewer, N., Rumberger, E., Bode, H., and Schulteam Esch, J. Anesthesiology 1985;63(Suppl. 3A):274.
Salata, J.J., Wasserstrom, J.A. and Jalife, J. J. Mol. Cell. Cardiol. 1983; 15:233.
Salata, J.J. and Jalife, J. J. Pharmacol. Exp. Ther. 1982;220:157.
Roewer, N., Kuck, K-H., Nienaber, Ch., Schroeder, E. and Schulteam Esch, J. Anesthesiology 1984;61 (Suppl. A):254.
Lascault, G., Asta, J., Cameron, D. and Waxman, M.B. Abstract. Circulation 1982;66 (Suppl): 11–294.
Durbin, Jr., C.G., Fisher, N.A. and Lynch, C. Abstract. Anesthesiology 1983;59(Suppl):A227.
Lynch, C, Durbin, C.G., Fisher, N.A., Veselis, R.A. and Althaus, J.S. Anesth. Analg. 1986;65:252.
Bailey, L.E., Shibata, S., Seriguchi, D.G. and Dresel, P.E. Life Sci. 1980;26:1061.
Hatae, J., Ohba, M. and Kawata, H. J. Mol. Cell. Cardiol. 1980;12:857.
Hollander, P.B. and Ramsey, C.C. Abstract. Fed. Proc. 1977;36:957.
Meszaros, J., Kecskemeti, V. and Szegi, J. Abstract. Proceedings of the 28th International Congress of Physiological Sciences, 1980, p. 579.
Meszaros, J., Kecskemeti, V. and Szegi, J. Eur. J. Pharmacol. 1981;74:181.
Boiling, S.F. and Gardner, T.J. J. Am. Coll. Cardiol. 1985;5:433.
Brooks, R.R., Carpenter, J.F., Jones, S.M., Gregory, CM. and Moore, A.F. Proceedings of the IUPHAR 9th International Congress of Pharmacology, Abstract 455P, 1984.
Butterfield, J.L., Carpenter, J.F., Jones, S.M., Brooks, R.R., Ellis, K.O., et al. Abstract. Pharmacologist 1983;25:246.
Saltzman, L.S., Kates, R.A., Corke, B.C., Norfleet, E.A. and Heath, K.R. Anesth. Analg. 1984;63:473.
Ally, A. I., Horrobin, D.F., Manku, M.S., Morgan, R.O., Karmazyn, M., Karmali, R.A. and Cunnane, S.C. Can. J. Physiol. Pharmacol. 1978; 56:520.
Conte-Camerino, D., Lograno, M.D., Siro-Brigiani, G. and Megna, G. Eur. J. Pharmacol. 1983;92:291.
Bowman, W.C. and Khan, H.H. J. Phar. Pharmacol. 1977;29:628.
Graves, S., Dretchen, K.L. and Kruger, G.O. Eur. J. Pharmacol. 1978;47:29.
Mahmoudian, M., Dehpour, A.R. and Mofakham, S. Eur. J. Pharmacol. 1981;70:287.
Harris, J.D. and Benson, G.S. Urology 1980;16:229.
Ayyat, F.M., Lloyd, L.K. and Kuhlemeier, K.V. J. Urol. 1984;132:372.
Teague, C.T. and Merrill, D.C. Urology 1978;11:531.
Khalaf, I.M., Foley, G. and Elhilali, M.M. Investigative Urology 1979;17:188.
Hackler, R.H., Broecker, B.H., Klein, F.A. and Brady, S.M. J. Urol. 1980;124:78.
Pederson, E., Harving, H. and Klemar, B. J. Urol. 1978;119:403.
Amabile, G., Mercuri, N., Parisi, L., Floris, R. and Pirro, C. In: Benvenuti (ed.). Dantrolene sodium: new theraptutic approach to clinical problems of spasticity. 1982, Turin: Minerva Medica, p. 71
Ohta, H., Myojin, K., Sanada, J., Ikeda, H. and Ogawa, M. Hiroshima J. Anesth. 1986;22(Suppl.):1.
Colton, C.A. and Colton, J.S. Comp. Biochem. Physiol. 1979;64C:153.
Durant, N.N., Lee, C. and Katz, R.L. Eur. J. Pharmacol. 1980;68:403.
Roed, A. Eur. J. Pharmacol. 1982;83:83.
Ito, F., Fujitsuka, N. and Hanuichi, T. Brain Res. 1984;294:269.
Callanan, K. and Keenan, A.K. Irish J. Med. Sci. 1982;151:92.
Patti, F., Giammona, G., Reggio, A., Maccagnano, C, Rampello, L. et al. Acta Neurol. 1981;36:384.
Ellis, K.O. In: Benvenuti (ed.). Dantrolene sodium: new therapeutic approach to clinical problems of spasticity. 1982. Turin: Minerva Medicine, p. 35.
Yamawaki, S., Hotta, I., Tanaka, S., Uchitomi, Y. and Yanagawa, K. Hiroshima J. Anesth. 1986;22(Suppl.):47.
Pinder, R.M., Brogden, R.M., Speight, T.M. and Avery, G.S. Drugs 1977;13:2.
Farquhar, R, Leslie, G.C. and Part, N.J. Br. J. Pharmacol. 1986;88:79.
Janjic, D., Wollheim, C.B. and Sharp, G.W.G. Am. J. Physiol. 1982;243:59.
Sharp, G.W.G., Wiedenkeller, D.E. and Pian-Smith, M. Diabetalogia 1984;27:331A.
Francis, K.T. and Hamrick, M.E. Biochem. Pharmacol. 1980;29:1669.
Kojima, I., Kojima, K., Kreutter, D. and Rasmussen, H. J. Biol. Chem. 1984;259:14448.
Kojima, K., Kojima, I. and Rasmussen, H. Am. J. Physiool. 1984;247:645.
Kojima, I., Kojima, K. and Rasmussen, H. Am. J. Physiol. 1985;248:36.
Bates, M.D. and Conn, P.M. Endocrinology 1984;115:1380.
Tanaka, S., Shimonaka, H., Uematsu, H., Yamamoto, M., Shiojiri, H., Kawai, K. and Nozawa, Y. Hiroshima J. Anesth. 1986;22(Suppl.):9.
Fukuchi, H., Kuwata, N., Seki, Y. and Morio, M. Hiroshima J. Anaesth. 1979;15:21.
Fukuchi, H. and Morio, M. Hiroshima J. Anaesth. 1977;13(Suppl):119.
Tomonaga, F., Kobayashi, T., Yago, K., Kamiya, T., Ishii, M., Tanaka, R., Watanabe, S. and Nomiyama, S. Hiroshima J. Anaesth. 1979; 15(Suppl):101.
Gronert, G.A., Mansfield, E. and Theye, R.A. In: Aldrete, J.A. and Britt, B.A. (eds.). Second International Symposium on Malignant Hyperthermia. 1978. New York: Grune & Stratton, p. 535.
Drechsler, H. Anaesthesist 1981;30:257.
Editorial. FDA Drug Bulletin 1979;9:27.
Britt, B.A. Can. Anaesth. Soc. J. 1984;31:61.
Ryan, J.F. Int. Anesth. Clin. 1979; 17:153.
Mathieu, A., Gogosian, A.J., Ryan, J.F., Crone, R.K. and Crocker, D. Anesthesiology 1979;51:454.
Faust, D.K., Gergis, S.D. and Sokoll, M.D. Anesth. Analg. 1979;58:33.
Friesen, CM., Brodsky, J.B. and Dillingham, M.F. Can. Anaesth. Soc. J. 1979;26:319.
Liebenschutz, F., Mai, C. and Pickerodt, V.W.A. Br. J. Anesth. 1979;51:899.
Jones, S.E.F. and Thomas, C.H. Anaesthesia 1980;35:987.
Hoff, B., Taylor, C. and Kruel, J. (Letter). Critical Care Medicine 1980;8:699.
Harrison, G.G. S. Afr. Med. J. 1981;60:909.
Hamasaki, T., Isohata, J., Nomiyuama, S., Matoba, M., Nakata, F., Murakami, M. and Tanaka, R. Hiroshima J. Anesth. 1986;22(Suppl.):101.
Waite, P.D., Ballard, J.B. and Yonfa, A. J. Oral. Maxillofac. Surg. 1985;43:907.
Souliere, Jr., CR., Weintraub, S.J. and Kirchner, C. Arch. Otolaryngol. Head Neck Surg. 1986;112:564.
Baudendistel, L., Goudsouzian, N., Cote, C. and Strafford, M. Anaesthesia 1984;39:1000.
Kageshima, K., Yasuda, N., Kageyama, K., Nagano, O., Tanifuji, Y., Kobayashi, K. and Nishijima, H. Hiroshima J. Anesth. 1986;22(Suppl.):111.
Yamada, H., Ohwaki, A., Endoh, M., Noguchi, J., Takeda, J. and Kuribayshi, N. Hiroshima J. Anesth. 1986;22(Suppl.):117.
Aono, H., Hirakawa, M., Tachibana, T., Takeda, A., Takimoto, E. and Tsuchiya, M. Hiroshima J. Anesth. 1986;22(Suppl.):137.
Denborough, M.A. Int. Anesth. Clin. 1979;17:11.
Sedwick, L.A. and Romano, P.E. Surv. Ophthalmol. 1981;25:378.
Schvaneveldt, J.A. and Stankiewicz, J.A. The Laryngoscope 1981;81:918.
Landauer, B. Der Anaesthesist 1980;29:507.
Dohlman, L.E. Plastic and Reconstructive Surgery 1982;69:547.
Hopkins, S. Nursing Mirror 1980;151:30.
Flewellen, E.H. and Nelson, T.E. Anesthesiology 1978;51:1001.
Rampertaap, M.P. South. Med. J. 1986;79:331.
Burke, R.E., Fahn, S., Mayeux R., Weinberg, H., Louis, K. et al. Neurology 1981;31:1022.
Caroff, S.N. J. Clin. Psychiat. 1980;41:79.
Khan, A., Jaffe, J.H., Nelson, W.H. and Morrison, B. J. Clin. Psychiatry 1985;46:244.
Martin, M.L., Lucid, E.J. and Walker, R.W. Ann. Emerg. Med. 1985;14:354.
Kawada, H., Izumi, H., Miyazato, Y., Kazunaga, H., Hayabara, T., Uefuji, T. and Baba, E. Hiroshima J. Anesth. 1986;22(Suppl.):65.
In-Nami, H., Okada, K., Kasai, T. and Kobayashi, K. Hiroshima J. Anesth. 1986;22(Suppl.):59.
Yamawaki, S., Yanagawa, K., Uchitomi, Y., Yamanaka, T. and Matsuura, Y. Hiroshima J. Anesth. 1986;22(Suppl.):41.
Kaplan, R.F., Feinglass, N.G., Webster, W. and Mudra, S. JAMA 1986;255:642.
Ueta, I., Takayama, Y., Yoshimoto, Y., Yamamoto, S., Myojin, K. and Tamura, M. Hiroshima J. Anesth. 1986;22(Suppl.):53.
Araki, M., Takagi, A. and Sugita, H. Hiroshima J. Anesth. 1986;22(Suppl.):17.
Merry, S.N., Werry, J.S., Merry, A.F. and Birchall, N. Aust. N.Z. J. Med. 1983;13:70.
Tollefson, G. J. Clin. Psychopharmacology 1982;1:266.
Scarlett, J.D., Zimmerman, R. and Berkovic, S.F. Aust. N.Z. J. Med. 1983;13:70.
Caroff, S.M., Rosenberg, H., Fletcher, J.E., Heiman-Patterson, T.D. and Mann, S.C. Anesthesiology 1987; (in press).
Araki, M., Takagi, A., Kiguchi, I. and Sugita, H. Abstract. Muscle Nerv. 1986;9:221.
Editorial. Lancet 1984;1:545.
Szabadi, E. Br. Med. J. 1984;288:1399.
Katsube, T., Kobayashi, S., Yamaguchi, S., Yamashita, K. and Tsunematsu, T. Hiroshima J. Anesth. 1986;22(Suppl.):71.
Denborough, M.A. Med. J. Australia 1982;1:204.
Lydiatt, J.S. and Hill, G.E. JAMA 1981;246:41.
Gronert, G.A., Thompson, R.L. and Onofrio, B.M. Anesth. Analg. 1980;59:377.
Sakai, T., Hosokawa, S., Shibasaki, H., Goto, I., Kuroiwa, Y., Sonoda, H. and Murai, Y. Neurology 1983;33:495.
Chyatte, S.B. and Birdsong, J.H. Southern Med. J. 1971;64:830.
Gelenberg, A.J. and Poskanzer, D.C. Neurology 1973;23:1313.
Chyatte, S.B., Birdsong, J.H. and Roberson, D.L. Arch. Physical Med. Rehab. 1973;54:365.
Chyatte, S.B., Birdsong, J.H. and Bergman, B.A. Southern Med. J. 1971;64:180.
Mayer, N., Mecomber, S.A. and Herman, R. Am. J. Physical Med. 1973;52:18.
Basmajian, J.V. and Super, G.A. Arch. Physical Med. Rehab. 1973;54:60.
Chyatte, S.B. and Basmajian, J.V. Arch. Physical Med. Rehab. 1973;54:311.
Wilkinson, S.P., Portmann, B. and Williams, R. Gut 1979;20:33.
Molnar, G.E., Evangelista, L.A. and Kathirithamby, R. N.Y. State J. Med. 1978;78:1233.
Faling, L.J., Petusevsky, M.L. and Snider, G.L. Ann. Int. Med. 1980;93:151.
Mai, J. and Pedersen, E. Acta Neurol. Scand. 1979;59:309.
Weiser, R., Terenty, T., Hudgson, P. and Weightman, D. The Practitioner 1978;221:123.
Feit, H. Neurology 1979;29:1631.
Eberstein, A. and Goodgold, J. Exper. Neurol. 1978;62:804.
Glass, A. and Hannah, A. Personal communication, Kaiser Foundation Hospital, Terra Linda, California.
Joynt, R.L. and Leonard, Jr., J.A. Develop. Med. Child Neurol. 1980;22:755.
Herman, R., Mayer, N. and Mecomber, S.A. Am. J. Physical Med. 1972;51:296.
Chipman, M. and Kaul, S. Neurology 1972;22:401.
Meyler, W.J., Bakker, H., Kok, J.J., Agoston, S. and Wesseling, H. J. Neurol. Neurosurg. Psychiat. 1981;44:334.
Ketel, W.B. and Kolb, M.E. Curr. Med. Res. Opin. 1984;9:161.
Aquilar Bernal, O.R., Bender, M.A. and Lacy, M.E. J. Roy. Soc. Med. 1986;79:277.
Nogen, A.G. Child’s Brain 1979;5:420.
Collier, C.B. Anaesthesia 1979;34:152.
Plotz, J., Braun, J. and Stallenberger, R. Anaesthesist 1981;30:338.
American Hospital Formulary Service. Published by the American Society of Hospital Pharmacists, Bethesda, Md. 20814.
Agoston, S. (Letter.) Anaesthesia 1980;35:1012.
Cornette, M., Gillard, C. and Borll-Hermans, G. Acta neurol. belg. 1980;80:336.
Utili, R., Boitnott, J.K. and Zimmerman, H.J. Gastroenterology 1977;72:610.
Abernathy, CO., Utili, R., Zimmerman, H.J. and Ezekiel, M. Toxicol. Appl. Pharmacol. 1978;44:441.
Roy, S., Francis, K.T., Born, CK. and Hamrick, M.E. Res. Comm. Chem. Pathol. Pharmacol. 1980;27:507.
Francis, K.T. and Hamrick, M.E. Res. Comm. Chem. Pathol. Pharmacol. 1979;23:69.
Petusevsky, M.L., Faling, L.J., Rocklin, R.E., Snider, G.L., Merliss, A.D., Moses, J.M. and Dorman, S.A. JAMA 1979;242:2772.
Miller, D.H. and Haas, L.F. J. Neurol. Neurosurg. Psychiat. 1984;47:553.
Wan, H.H. and Tucker, J.S. Postgrad. Med. J. 1980;56:261.
Andrews, L.G., Muzumdar, A.S. and Pinkerton, A.C. Can. Med. Assn. J. 1975; 112:148.
Rivera, V.M., Breitback, W.B. and Swanke, L. JAMA 1975;233:863.
Greenspun, B. and Pacho, A, Arch. Phys. Med. Rehab. 1981;62:521.
Pembroke, A.C., Saxena, S.R., Kataria, M. and Silkha, K.D. Brit. J. Dermatol. 1981;104:465.
Chapin, J.W., Lou, CG. and Wingard, D.W. (Letter.) Anesthesiology 1981;54:527.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Britt, B.A. (1987). Dantrolene—An Update. In: Britt, B.A. (eds) Malignant Hyperthermia. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2079-1_14
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2079-1_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9233-3
Online ISBN: 978-1-4613-2079-1
eBook Packages: Springer Book Archive